Notification Letter and Request Form for Non-registered Shareholders
Filed with HKEX · Stock code 2137 · · 2 pages · English and Chinese
The Current Corporate Communication of the Company, in both English and Chinese versions, is available on the Company’s website at http://www.briibio.com and the website of The Stock Exchange of Hong Kong Limited at http://www.hkexnews.hk. If you wish to receive printed version of the Current Corporate Communication, please complete the Request Form on the reverse side and return it to the Company
Brii Biosciences Limited on 6ix
Earlier from Brii Biosciences
- Notification Letter and Change Request Form for Registered Shareholders
- 2026 Interim Report
- Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
- Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
- Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
Later from Brii Biosciences
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Grant of share options and restricted share units
- Next Day Disclosure Return
- VOLUNTARY ANNOUNCEMENT Launch of BRiSC, an siRNA Therapeutics Discovery Platform
Follow Brii Biosciences into a list and get an email when it puts out news.
Follow Brii Biosciences